Plantable Health Inc.

As of June 30, 2023, Plantable Health Inc. has 63.25M shares outstanding.

These figures are as of June 30, 2023. The price-to-sales ratio is 0.81, and the price-to-book ratio stands at -0.53.

These figures are as of June 30, 2023. The EV/Sales ratio of 0.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of June 30, 2023, Plantable Health Inc. maintains a current ratio of 1.95, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 222.34, indicating elevated leverage, while an interest coverage ratio of -193.61 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2023. Return on assets (ROA) is negative at -157.43, reflecting losses generated across the asset base. Inventory turnover of 12.35 indicates how many times Plantable Health Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2023, Plantable Health Inc. posted a gross margin of 19.72, reflecting its pricing power and cost economics. The operating margin of -192.56 and net profit margin of -196.84 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2023. Free cash flow yield is negative at -196.92: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 13.94, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Plantable Health Inc. shareholders.

As of June 30, 2023, Plantable Health Inc. has an Altman Z-Score of -70.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.